4971794 Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili

4971794 Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili

124 PATENT ABSTRACTS 4971723 4971794 PARTIALLY DEBRANCHED STARCHES AND ENZYMATIC PROCESS FOR PREPARING THE STARCHES PRODUCTION OF ANTIBODIES USING...

60KB Sizes 1 Downloads 62 Views

124

PATENT ABSTRACTS 4971723

4971794

PARTIALLY DEBRANCHED STARCHES AND ENZYMATIC PROCESS FOR PREPARING THE STARCHES

PRODUCTION OF ANTIBODIES USING A MIXTURE OF STRAINS O F E. C O L I C O L L E C T I V E L Y EXPRESSING TYPE I PILI, CFA I P I L I , C F A II P I L I A N D K 8 8 P I L I

Chung-Wai Chiu assigned to National Starch and Chemical Investment Holding Corporation This invention provides partially debranched starch, prepared by enzymatic hydrolysis of the alpha-l, 6-D glucosidic bonds of the starch, comprising amylopectin, partially debranched amylopectin and up to 80%, by weight, short chain amylose. This invention also provides a method for preparing this starch, employing an endo alpha-l, 6-D glucanohydrolase. The starch of this invention is useful for lending a fat-like, lubricating texture to aqueous dispersions, forming stable opaque clouds, forming thermoreversible gels, high strength gels and waterresistant films, and for thickening and bonding.

Margaret A Linggood, Philip Porter, Jonathan Powell, Bedfordshire, United Kingdom assigned to Unilever Patent Holdings B V Antibodies are produced by hyperimmunizing a mammal, such as cow, with a vaccine derived from E. coli bacteria. The bacterial strains in the vaccine are selected on the basis of their virulence characteristics, especially adhesion factors (pili), associated with gastroenteric disease in humans. The antibodies can be recovered from the mammal's milk or serum, and used in human foods.

4971~1 4971792 MONOCLONAL ANTIBODIES AGAINST GLYCOLIPID ANTIGENS Zenon Steplewski, Hilary Koprowski, Magdelena Thurin assigned to The Wistar Institute The present invention is directed to in vitro and in vivo immunodiagnosis and immunotherapy using monoclonal antibodies reactive with difucosyl blood group antigens Y-6 and B-7-2.

4971793 SUBUNIT

CANINE PARVOVIRUS VACCINE

Harry A Wood, Colin R Parrish assigned to Boyce Thompson Institute for Plant Research Inc; Cornell Research Foundation Inc A recombinant subunit vaccine for protecting dogs against infection caused by canine parvovirus comprising VP-2 protein produced during replication of a recombinant baculovirus in insect tissue culture cells or insects which are a permissive host for the replication of selected baculoviruses.

PROCESS FOR PREPARING ENZYME ELECTRODES Ryuz Hayashi, Aki Kariyone, Higashiosaka, Japan assigned to Kanzaki Paper Manufacturing Co Ltd An enzyme electrode is prepared by a process wherein an albumin solution containing 0.05 to 0.5% by weight of a multifunctional aldehyde is applied onto the surface of an electroconductive substrate while maintaining the atmospheric temperature at 0 degrees to 20 degrees C. to thereby form a crosslinked albumin layer on the surface of the electroconductive substrate. Thereafter a solution containing 0.5% by weight or less of a multifunctional aldehyde and a predetermined amount of an oxidase capable of producing hydrogen peroxide (H202) is applied on the surface of the previously formed crosslinked albumin layer to form a H202 productive oxidase containing layer.

4971~2 DIAGNOSTIC PROBE FOR RHEUMATOID ARTHRITIS PREDISPOSITION Gerald T Nepom assigned to Virginia Mason Research Center